235 related articles for article (PubMed ID: 29051403)
1. Axillary treatment of patients with breast cancer and micrometastatic disease in the sentinel lymph node Our experience.
Morlino A; La Torre G; Patitucci G; Cammarota A
Ann Ital Chir; 2017; 88():360-364. PubMed ID: 29051403
[TBL] [Abstract][Full Text] [Related]
2. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
[TBL] [Abstract][Full Text] [Related]
4. Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Głowacka-Mrotek I; Sowa M; Biedka M; Kołacińska A
Breast J; 2018 Sep; 24(5):724-729. PubMed ID: 29476570
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
7. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
[TBL] [Abstract][Full Text] [Related]
8. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
9. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
[TBL] [Abstract][Full Text] [Related]
10. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
11. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
12. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
[TBL] [Abstract][Full Text] [Related]
13. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
[TBL] [Abstract][Full Text] [Related]
14. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
[TBL] [Abstract][Full Text] [Related]
15. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
[TBL] [Abstract][Full Text] [Related]
16. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
[TBL] [Abstract][Full Text] [Related]
17. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
Ozkurt E; Yardımcı E; Tükenmez M; Ersoy YE; Yilmaz R; Cabioğlu N; Karanlık H; Kulle CB; Malya FU; Önder S; Gucin Z; İğci A; Özmen V; Dinççağ AS; Müslümanoğlu M
Breast J; 2019 Jan; 25(1):96-102. PubMed ID: 30419607
[TBL] [Abstract][Full Text] [Related]
19. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
